The biodegradable segment by product is estimated to lead the market growth during the forecast period.
According to The Insight Partners market research study of “South and Central America Dermal Fillers Market Forecast to 2028 - COVID-19 Impact and Regional Analysis by Product, Material, Application, End User and Country.” The South and Central America dermal fillers market is expected to reach US$ 600.67 million by 2028 from US$ 295.63 million in 2021; it is estimated to grow at a CAGR of 10.7% from 2021 to 2028. The report highlights trends prevailing in the South and Central America dermal fillers market and the factors driving market along with those that act as hindrances.
In recent years, the adoption of minimally invasive procedures has increased worldwide. Several minimally invasive dermatological techniques have been developed for facial rejuvenation. Injectable dermal fillers can be injected through a needle into the upper layers of the dermis to treat superficial fine wrinkles or into the deep dermis or subcutaneous space for facial volume augmentation. According to the statistics from the American Society of Plastic Surgeons (ASPS), more than 2.7 million dermal filler procedures were performed in 2019. Further, Allergan stated that the unit sales of dermal filler treatments increased by 17%. Age is a significant factor governing specific needs regarding medical aesthetic procedures. People of age 35–55 prefer minimally invasive aesthetic procedures over surgery. Minimally invasive cosmetic and aesthetic procedures have now become an established interdisciplinary topic, and plastic surgeons showing greater will to explore them. The rise of nonsurgical technologies and new treatment options has made aesthetics more accessible to a broader audience. Collectively, the greater benefits and accuracy of minimally invasive procedures over traditional surgical procedures are expected to drive the market during the forecast period. The ever-increasing interest in retaining a youthful physical appearance has facilitated various minimally invasive dermatological techniques. With the ever-increasing popularity of nonsurgical enhancement and a growing number of patients who have been treated, the demand for fillers continues to rise. Also, the surging inclination among people of age of 30–65 with signs of aging, such as lack of skin elasticity, wrinkles, and dark spots, is anticipated to drive the demand for dermal fillers in the coming years.
Latin American countries are witnessing continuous rise in COVID-19 cases. Currently, countries in this region are rapidly increasing clinical programs to fight the disease, and the healthcare sectors have redirected their focus toward its management. Many dermatology clinics were shut down in 2020. Thus, the dermal fillers market in South and Central America has witnessed negative effect of the COVID-19 pandemic.
The South and Central America derma fillers market, by product is segmented into biodegradable and non-biodegradable. The South and Central America derma fillers market, by material is segmented into calcium hydroxylapatite, hyaluronic acid, collagen, poly-l-lactic acid, polymethylmethacrylate (PMMA), fat, other materials. Based on application, the South and Central America dermal fillers market is segmented into facial line correction treatment, lip enhancement, face lift, scar treatment, and others. Based on end user, the South and Central America dermal fillers market is segmented into dermatology clinics, multispecialty hospitals, ambulatory surgical centers, and others. Geographically, the South and Central America dermal fillers market can be sub-segmented into Brazil, Argentina and Rest of South and Central America.
AbbVie Inc., Galderma, Merz Pharma, Suneva Medical, HUADONG MEDICINE CO., LTD, and Prollenium Medical Technologies are among the leading companies operating in the South and Central America dermal fillers market.